Cite

    Beziat, G. et al. (2020). Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report. Clinical case reports. 8 (2), pp. 269-273. [Online].